Bacteriuria increases the risk of edematous attacks in hereditary angioedema with C1-inhibitor deficiency

被引:10
作者
Zotter, Z. [1 ,2 ]
Veszeli, N. [1 ]
Kohalmi, K. V. [1 ]
Varga, L. [1 ]
Imreh, E. [3 ]
Kovacs, G. [2 ]
Nallbani, M. [2 ]
Farkas, H. [1 ]
机构
[1] Semmelweis Univ, Dept Internal Med 3, Budapest, Hungary
[2] Hungarian Def Forces, Med Ctr, Dept Urol, Budapest, Hungary
[3] Semmelweis Univ, Dept Lab Med, Budapest, Hungary
关键词
bacteriuria; C1-inhibitor deficiency; edematous attack; hereditary angioedema; trigger factor; ASYMPTOMATIC BACTERIURIA; KININ;
D O I
10.1111/all.13034
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Urinary tract infections are considered among the most common infectious disorders in humans. Various infections may have a role in inducing HAE attacks. Our study intended to evaluate bacteriuria in the urinalysis of patients with C1-INH-HAE. Urine specimens contributed by 139 patients with C1-INH-HAE at the annual control visits were studied retrospectively for microorganisms. We analyzed the presence of bacteriuria in relation to the clinical symptoms. Taking into account three randomly selected urine specimens, we found that the cumulative number of edematous attacks was higher in patients with bacteriuria than in those without (P = 0.019, P = 0.022, P = 0.014). Considering the same patients, attack number was significantly higher (14.51 vs 8.63) in patients with bacteriuria than in those without (P < 0.0001). In patients with bacteriuria, we found a higher incidence of edema formation during the year before evaluation, which may suggest the triggering role of bacteriuria in the occurrence of edematous episodes.
引用
收藏
页码:1791 / 1793
页数:3
相关论文
共 50 条
  • [41] Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema
    Lumry, William R.
    Craig, Timothy
    Zuraw, Bruce
    Longhurst, Hilary
    Baker, James
    Li, H. Henry
    Bernstein, Jonathan A.
    Anderson, John
    Riedl, Marc A.
    Manning, Michael E.
    Keith, Paul K.
    Levy, Donald S.
    Caballero, Teresa
    Banerji, Aleena
    Gower, Richard G.
    Farkas, Henriette
    Lawo, John-Philip
    Pragst, Ingo
    Machnig, Thomas
    Watson, Douglas J.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (05) : 1733 - +
  • [42] Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE)
    Parsopoulou, Faidra
    Loules, Gedeon
    Zamanakou, Maria
    Csuka, Dorottya
    Szilagyi, Agnes
    Kompoti, Maria
    Porebski, Grzegorz
    Psarros, Fotis
    Magerl, Markus
    Valerieva, Anna
    Staevska, Maria
    Obtulowicz, Krystyna
    Maurer, Marcus
    Speletas, Matthaios
    Farkas, Henriette
    Germenis, Anastasios E.
    [J]. FRONTIERS IN ALLERGY, 2022, 3
  • [43] Clinical and genetic features of hereditary angioedema with and without C1-inhibitor (C1-INH) deficiency in Japan
    Hashimura, Chinami
    Kiyohara, Chikako
    Fukushi, Jun-Ichi
    Hirose, Tomoya
    Ohsawa, Isao
    Tahira, Tomoko
    Horiuchi, Takahiko
    [J]. ALLERGY, 2021, 76 (11) : 3529 - 3534
  • [44] C1-inhibitor deficiencies (hereditary angioedema): Where are we with therapies?
    R. J. Lock
    M. M. Gompels
    [J]. Current Allergy and Asthma Reports, 2007, 7 : 264 - 269
  • [45] A focus on the use of subcutaneous C1-inhibitor for treatment of hereditary angioedema
    Villavicencio, Maria Fernanda
    Craig, Timothy
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (05) : 451 - 455
  • [46] Mechanisms involved in hereditary angioedema with normal C1-inhibitor activity
    Shamanaev, Aleksandr
    Dickeson, S. Kent
    Ivanov, Ivan
    Litvak, Maxim
    Sun, Mao-Fu
    Kumar, Sunil
    Cheng, Quifang
    Srivastava, Priyanka
    He, Tracey Z.
    Gailani, David
    [J]. FRONTIERS IN PHYSIOLOGY, 2023, 14
  • [47] Safety and Efficacy of Prophylactic Nanofiltered C1-inhibitor in Hereditary Angioedema
    Zuraw, Bruce L.
    Kalfus, Ira
    [J]. AMERICAN JOURNAL OF MEDICINE, 2012, 125 (09) : 938.e1 - 938.e7
  • [48] Hereditary angioedema:: A decade of human C1-inhibitor concentrate therapy
    Farkas, Henriette
    Jakab, Laszlo
    Temesszentandrasi, Gyoergy
    Visy, Beata
    Harmat, Gyoergy
    Fust, George
    Szeplaki, Gabor
    Fekete, Bela
    Karadi, Istvan
    Varga, Lilian
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (04) : 941 - 947
  • [49] Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks
    Craig, Timothy
    Zuraw, Bruce
    Longhurst, Hilary
    Cicardi, Marco
    Bork, Konrad
    Grattan, Clive
    Katelaris, Constance
    Sussman, Gordon
    Keith, Paul K.
    Yang, William
    Hebert, Jacques
    Hanzlikova, Jana
    Staubach-Renz, Petra
    Martinez-Saguer, Inmaculada
    Magerl, Markus
    Aygoren-Pursun, Emel
    Farkas, Henriette
    Reshef, Avner
    Kivity, Shmuel
    Neri, Sergio
    Crisan, Ioana
    Caballero, Teresa
    Baeza, Maria L.
    Dolores Hernandez, Maria
    Li, Henry
    Lumry, William
    Bernstein, Jonathan A.
    Hussain, Iftikar
    Anderson, John
    Schwartz, Lawrence B.
    Jacobs, Joshua
    Manning, Michael
    Levy, Donald
    Riedl, Marc
    Christiansen, Sandra
    Feuersenger, Henrike
    Pragst, Ingo
    Mycroft, Sarah
    Pawaskar, Dipti
    Jacobs, Iris
    Zuraw, Bruce L.
    Cicardi, Marco
    Craig, Timothy
    Longhurst, Hilary
    Grattan, Clive
    Grattan, Clive
    Bork, Konrad
    Kreuz, Wolfhart
    Jacobs, Iris
    Pragst, Ingo
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (06) : 1793 - +
  • [50] Per-Attack Reporting of Prodromal Symptoms Concurrent with C1-Inhibitor Treatment of Hereditary Angioedema Attacks
    Michael J. Prematta
    Againdra K. Bewtra
    Robyn J. Levy
    Richard L. Wasserman
    Kraig W. Jacobson
    Thomas Machnig
    Timothy J. Craig
    [J]. Advances in Therapy, 2012, 29 : 913 - 922